Globus Medical GMED Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's additional paid-in capital?
- Globus Medical (GMED) reported additional paid-in capital of $3.21B in Q1 2026.
- How has Globus Medical's additional paid-in capital changed year-over-year?
- Globus Medical's additional paid-in capital increased by 5.0% year-over-year, from $3.05B to $3.21B.
- What is the long-term trend for Globus Medical's additional paid-in capital?
- Over 5 years (2020 to 2025), Globus Medical's additional paid-in capital has grown at a 47.3% compound annual growth rate (CAGR), from $457.16M to $3.17B.
- What does additional paid-in capital mean?
- Capital contributed by investors above the par value of the company's stock.
- How do you interpret additional paid-in capital?
- An increase typically signals equity issuance or stock-based compensation activity, while a decrease is rare and usually related to share buybacks.
- How does additional paid-in capital compare across companies?
- Commonly high for growth-oriented companies that have historically relied on equity financing to fund operations.